Mar 26, 2025

‘Ultrarapid’ genomic testing could shift paradigm for cancer treatment

Jul 17, 2023

The ‘incredible’ way the HPV virus causes cancer and what that means for treating it

Jun 26, 2023

Why some patients with a rare but deadly leukemia fare much better than others

Jul 06, 2021

Learning how to fly blind

Feb 19, 2021

OICR-supported collaboration discovers new method to stunt the growth of brain cancers

Aug 28, 2020

Tumour traces in blood could predict which cancer patients will benefit from immunotherapy

Aug 25, 2020

New advances towards targeted therapies for triple negative breast cancer

Jul 29, 2020

Q&A with new OICR investigator Dr. Courtney Jones on benefitting patients through research

Jul 24, 2020

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients

Jun 23, 2020

Diagnosing brain tumours with a blood test

Mar 02, 2020

Study reveals roots of leukemia that current chemotherapies can’t reach

Jan 13, 2020

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer

Oct 15, 2019

‘I’m here to help address important and challenging questions in health’

Jul 17, 2019

New research unfolds the DNA “origami” behind brain cancers

Jul 03, 2019

Five fellows, four labs, three years, two countries, and a generous donation

Mar 19, 2019

Understanding intermediate-risk prostate cancer: The whole may be greater than the sum of its parts

Oct 16, 2018

Bringing cutting-edge imaging techniques to clinical trials

Aug 22, 2018

Heliotrope: Personalizing cancer treatment decisions

Jul 10, 2018

Targeting epigenetic proteins could help prevent breast cancer

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Sep 06, 2017

Innovative study brings next-generation genomic sequencing to more Ontario cancer patients

Aug 09, 2017

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

Jul 12, 2017

Ovarian cancer research team working to exploit disease's vulnerabilities

Jul 11, 2017

How OICR is helping to boost the body’s ability to fight cancer

Jun 28, 2017

Ontario researchers identify rare therapy-resistant stem cells linked to AML patient relapse

May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

May 03, 2017

Study bringing more precision medicine to Ontario’s cancer patients

Apr 25, 2017

Dr. John Dick presented with CIHR Gold Leaf Award for Discovery

Jan 26, 2017

Dr. John Dick to present 2017 Tobias Award Lecture

Jan 05, 2017

Researchers disprove link between vasectomies and prostate cancer using Ontario health data

Dec 07, 2016

Cancer stem cell scientists create tool to aid in planning treatment for leukemia

Dec 01, 2016

Expanding the DNA alphabet to understand cancer

Sep 16, 2016

“PEARLs” to improve photo-thermal cancer therapy

Aug 17, 2016

New retrospective study aims to identify mutations to better diagnose breast cancer in the future

Aug 16, 2016

New research published on the role of noncoding RNA in prostate cancer

Aug 09, 2016

Patients need access to more stem cells for transplants. Researchers have now identified the genetic switch that could turn on the supply

Jul 14, 2016

Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood for future clinical use

Jul 14, 2016

“Smart” nanoparticle called PEARLS a promising gem to target, treat tumours with greater precision

Jun 28, 2016

OICR’s Dr. Clare Jeon discusses how the discovery of protein signatures could lead to cheaper, easier diagnostic tests for prostate cancer

Jun 16, 2016

Study examines mental health in common ethnic minorities in Ontario

May 13, 2016

New research better defines which patients will respond to colorectal cancer drug

May 01, 2016

Dr. Gang Zheng named to AIMBE College of Fellows for nanotechnology research

May 01, 2016

OICR invests in early-stage Ontario oncology drug development

Jan 07, 2016

Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario

Dec 29, 2015

OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers

Dec 22, 2015

Stand Up to Cancer Canada announces breast cancer Dream Team

Oct 14, 2015

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers

Jun 01, 2015

The Ontario Institute for Cancer Research invests $4.6 million to support pancreatic cancer research

May 25, 2015

Groundbreaking Research Moves One Step Closer to Personalizing Prostate Cancer Treatment

Jan 07, 2015

Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers